CD4 and cancer: These findings were comparable with those described in other SSA countries.9,13,27-30 ADCs, which accounted for 40% of all cancers among HIV-positive patients, are a result of advanced immunosuppression suggested by the median CD4 count well below 200 cells/ul at HIV diagnosis among the study population.